 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 October 1996 | Volume 125 Issue 8 | Pages 653-657
Background: The high prevalence of classic cardiac risk factors in patients with non-insulin-dependent diabetes mellitus does not explain the increased cardiovascular-related morbidity and mortality in these patients. Fibrinogen may have a role in this excess risk.
Objective: To evaluate the following in patients with non-insulin-dependent diabetes mellitus: 1) the distribution of plasma fibrinogen levels and the prevalence of hyperfibrinogenemia and 2) the association of fibrinogen level with hemoglobin A1c value and albumin excretion rate.
Design: Cross-sectional study of a population-based cohort.
Setting: Rural area in northern Italy.
Patients: 1574 patients with non-insulin-dependent diabetes mellitus who represented 81% of the initial cohort of 1967 patients.
Measurements: Albumin excretion rate was measured in urine samples obtained during an overnight collection. Venous blood samples were collected while patients fasted.
Results: Fibrinogen levels were available for 1525 of the 1574 patients who were examined (669 men and 856 women). The mean age (±SD) was 67.3 ± 10.3 years for men and 70.7 ± 10.7 years for women. The mean plasma fibrinogen level (±SD) was 3.6 ± 0.9 g/L; levels slightly differed between men and women. In 50.3% of patients, plasma fibrinogen level exceeded 3.5 g/L. In men, fibrinogen level increased with age (P < 0.001). In both men and women, fibrinogen level adjusted for age and sex was significantly and linearly related to hemoglobin A1c value (P < 0.001) and albumin excretion rate (P < 0.001). In a multiple regression analysis, hemoglobin A1c value (b = 0.06; P < 0.001) and albumin excretion rate (b = 0.09; P = 0.005) were associated with fibrinogen level independent of other cardiovascular risk factors (sex, age, hypertensive status, total cholesterol level, smoking habit, and body mass index).
Conclusions: Patients with non-insulin-dependent diabetes mellitus had a high prevalence of hyperfibrinogenemia. Fibrinogen level was independently associated with hemoglobin A1c value and albumin excretion rate, which suggests that fibrinogen may be involved in the increased cardiovascular risk of patients with diabetes mellitus.
Author and Article Information
From University of Torino, Torino, Italy; and Santo Spirito Hospital, Casale Monferrato, Italy.
BRIEF COMMUNICATION
Association of Fibrinogen with Glycemic Control and Albumin Excretion Rate in Patients with Non-Insulin-Dependent Diabetes Mellitus
Grant Support: In part by a grant from Ministero della Universita' e della Ricerca Scientifica e Tecnologica (MURST), Italy.
Acknowledgments: The authors thank A. Caramellino, MD, A. Rosso, MD, I. Camona, RN, A. Raimondi, RN, and G. Comoglio, RN, for their collaboration. The authors also thank the members of the Casale Monferrato General Practitioners Study Group, all of whom are from Casale Monferatto, Alessandria, Italy: A. Alesso, A. Angelini, M. Annarotone, C. Arena, F. Aviotti, A. Bagna, L. Balbo, G. Barigazzi, F. Barone, G. Battezzati, R. Bedon, M. Bertiglia, G. Bertinetti, P.L. Bigliati, G. Bocchino, F. Boero, F. Botto, U. Bozzelli, M. Busca, E. Cabiati, A. Calcagno, R. Caprioglio, G. Caprino, B. Carelli, G. Casalino, G. Casalone. G. Castelli, G. Coggiola, G.F. Coppo, N. Corda, P.M. Croce, G. Croppi, G. Crosio, M. Dealessi, N. Del Boca, P. Demarchi, P. Deregibus, M. Fasano, L. Formaggio, N. Forno, F. Gabba, M. Gallesi, D. Gavazza, G. Giorcelli, B. Giordano, C. Grangiotti, P. Graziano, R. Guaschino, F. Iacometti, G.P. Irico, P.L. Lavagno, L. Lavazza, P. Lavazza, M. L. Liverani, F.P. Longo, D. Maggi, N. Maltoni, L. Martinelli, M. Mazzucco, G. Mortara, M.L. Mosso, L. Musso, G. Negri, A. Oglietti, P. Ollandini, F. Ombra, E. Orcesi, V. Ottavis, S. Ottolenghi, A. Panattoni, F. Papili, V. Pasolini, R. Patrucco, G. Perani, G.D. Picasso, P.G. Pisano, L. Poy, P. Poncina, P.L. Porta, L. Ramezzana, C. Rendo, D. Robotti, L. Rondano, F. Rossi, G. Rosso, C. Spatazza, E. Spinoglio, F. Tedesco, E. Tosco, M. Tribocco, G. Trinchero, G. Vallaro, G. Varaldo, C. Verrua, G. Verrua, C. Zanello, G. Zavattaro, and M. Zola.
Requests for Reprints: Graziella Bruno, MD, Dipartimento di Medicina Interna, corso Dogliotti 14, I-10126 Torino, Italy.
Current Author Addresses: Drs. Bruno, Cavallo-Perin, Borra, D'Errico, and Pagano: Dipartimento di Medicina Interna, corso Dogliotti 14, I-10126 Torino, Italy.
This article has been cited by other articles:
|
|
 |
|
  T.-J. Wu, H.-Y. Ou, C.-W. Chou, S.-H. Hsiao, C.-Y. Lin, and P. C. Kao Decrease in Inflammatory Cardiovascular Risk Markers in Hyperlipidemic Diabetic Patients Treated with Fenofibrate Ann. Clin. Lab. Sci., January 1, 2007; 37(2): 158 - 166. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. G. Gustavsson and C.-D. Agardh Markers of inflammation in patients with coronary artery disease are also associated with glycosylated haemoglobin A1c within the normal range Eur. Heart J., December 1, 2004; 25(23): 2120 - 2124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Bruno, F. Merletti, A. Biggeri, G. Bargero, S. Ferrero, C. Runzo, S. Prina Cerai, G. Pagano, and P. Cavallo-Perin Metabolic Syndrome as a Predictor of All-Cause and Cardiovascular Mortality in Type 2 Diabetes: The Casale Monferrato Study Diabetes Care, November 1, 2004; 27(11): 2689 - 2694. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bruno, A. Biggeri, F. Merletti, G. Bargero, S. Ferrero, G. Pagano, and P. C. Perin Low Incidence of End-Stage Renal Disease and Chronic Renal Failure in Type 2 Diabetes: A 10-year prospective study Diabetes Care, August 1, 2003; 26(8): 2353 - 2358. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Bruno, F. Merletti, A. Biggeri, G. Bargero, S. Ferrero, G. Pagano, and P. C. Perin Progression to Overt Nephropathy in Type 2 Diabetes: The Casale Monferrato Study Diabetes Care, July 1, 2003; 26(7): 2150 - 2155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Klein, S. J. Hunter, A. J. Jenkins, D. Zheng, A. J. Semler, J. Clore, W. T. Garvey, and The DCCT/EDIC Study Group Fibrinogen Is a Marker for Nephropathy and Peripheral Vascular Disease in Type 1 Diabetes: Studies of plasma fibrinogen and fibrinogen gene polymorphism in the DCCT/EDIC cohort Diabetes Care, May 1, 2003; 26(5): 1439 - 1448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Saito, A. R. Folsom, F. L. Brancati, B. B. Duncan, L. E. Chambless, and P. G. McGovern Nontraditional Risk Factors for Coronary Heart Disease Incidence among Persons with Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study Ann Intern Med, July 18, 2000; 133(2): 81 - 91. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Gaster and I. B. Hirsch The Effects of Improved Glycemic Control on Complications in Type 2 Diabetes Arch Intern Med, January 26, 1998; 158(2): 134 - 140. [Abstract] [Full Text] [PDF]
|
|
Article
